Sensitive high-performance liquid chromatographic method for the determination of coumarin in plasma. 1993

D Lamiable, and R Vistelle, and T Trenque, and R Fay, and H Millart, and H Choisy
Laboratoire de Pharmacologie, Hôpital Maison-Blanche, Reims, France.

A high-performance liquid chromatographic method was developed for the determination of coumarin in plasma at low concentrations. The method involves a single-step extraction of the alkalinized sample with hexane and subsequent evaporation of the organic phase in the presence of hydrochloric acid to collect and concentrate the coumarin. Analysis of the acidic phase was performed on a C8 column and coumarin was detected by measuring the UV absorbance at 275 nm. The limit of detection was 0.3 microgram l-1. The assay was used to study the evolution of concentrations of coumarin in one volunteer after oral administration of a single 10-mg dose.

UI MeSH Term Description Entries
D008297 Male Males
D002138 Calibration Determination, by measurement or comparison with a standard, of the correct value of each scale reading on a meter or other measuring instrument; or determination of the settings of a control device that correspond to particular values of voltage, current, frequency or other output. Calibrations
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D003374 Coumarins Synthetic or naturally occurring substances related to coumarin, the delta-lactone of coumarinic acid. 1,2-Benzopyrone Derivatives,1,2-Benzopyrones,Coumarin Derivative,Coumarine,1,2-Benzo-Pyrones,Benzopyran-2-ones,Coumarin Derivatives,Coumarines,1,2 Benzo Pyrones,1,2 Benzopyrone Derivatives,1,2 Benzopyrones,Benzopyran 2 ones,Derivative, Coumarin,Derivatives, 1,2-Benzopyrone,Derivatives, Coumarin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D013056 Spectrophotometry, Ultraviolet Determination of the spectra of ultraviolet absorption by specific molecules in gases or liquids, for example Cl2, SO2, NO2, CS2, ozone, mercury vapor, and various unsaturated compounds. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Ultraviolet Spectrophotometry
D015203 Reproducibility of Results The statistical reproducibility of measurements (often in a clinical context), including the testing of instrumentation or techniques to obtain reproducible results. The concept includes reproducibility of physiological measurements, which may be used to develop rules to assess probability or prognosis, or response to a stimulus; reproducibility of occurrence of a condition; and reproducibility of experimental results. Reliability and Validity,Reliability of Result,Reproducibility Of Result,Reproducibility of Finding,Validity of Result,Validity of Results,Face Validity,Reliability (Epidemiology),Reliability of Results,Reproducibility of Findings,Test-Retest Reliability,Validity (Epidemiology),Finding Reproducibilities,Finding Reproducibility,Of Result, Reproducibility,Of Results, Reproducibility,Reliabilities, Test-Retest,Reliability, Test-Retest,Result Reliabilities,Result Reliability,Result Validities,Result Validity,Result, Reproducibility Of,Results, Reproducibility Of,Test Retest Reliability,Validity and Reliability,Validity, Face

Related Publications

D Lamiable, and R Vistelle, and T Trenque, and R Fay, and H Millart, and H Choisy
June 1999, Pharmaceutica acta Helvetiae,
D Lamiable, and R Vistelle, and T Trenque, and R Fay, and H Millart, and H Choisy
November 1985, Journal of chromatography,
D Lamiable, and R Vistelle, and T Trenque, and R Fay, and H Millart, and H Choisy
September 1997, Journal of chromatography. B, Biomedical sciences and applications,
D Lamiable, and R Vistelle, and T Trenque, and R Fay, and H Millart, and H Choisy
January 1987, Journal of chromatography,
D Lamiable, and R Vistelle, and T Trenque, and R Fay, and H Millart, and H Choisy
October 1999, Journal of chromatography. B, Biomedical sciences and applications,
D Lamiable, and R Vistelle, and T Trenque, and R Fay, and H Millart, and H Choisy
March 1986, Journal of chromatography,
D Lamiable, and R Vistelle, and T Trenque, and R Fay, and H Millart, and H Choisy
August 1993, Therapeutic drug monitoring,
D Lamiable, and R Vistelle, and T Trenque, and R Fay, and H Millart, and H Choisy
August 1999, Journal of chromatography. B, Biomedical sciences and applications,
D Lamiable, and R Vistelle, and T Trenque, and R Fay, and H Millart, and H Choisy
September 2001, International journal of clinical pharmacology and therapeutics,
D Lamiable, and R Vistelle, and T Trenque, and R Fay, and H Millart, and H Choisy
October 1983, Journal of chromatography,
Copied contents to your clipboard!